MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Surgical & Diagnostic Technology _ Vascular, PAD (Peripheral Arterial Disease & CLI (Critical Limb Ischemia)
Pathway Medical Technologies
Parents
Architects: Surgical & Diagnostic Technology _ Vascular, PAD (Peripheral Arterial Disease & CLI (Critical Limb Ischemia)
Bayer MedRad
Companies: Acquired_(M&A)
Children
2011: Exclusive: Pathway Medical Technologies To Be Acquired by Bayer’s Medrad Unit for $125M (2011)
About 15,000 patients in the U.S. have had a Pathway procedure done, and about 300 doctors are routinely using the device
CEO Paul Buckman, Pathway
Founded 1989
Investors are Forbion Capital Partners, Giza Venture Capital, HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, WRF Capital, and individual investors
Pathway Medical Grinds It Out, Seeks Profit Formula, Three Years After FDA Approval (2011)
Pathway’s device uses a tiny stainless-steel drill mounted on a catheter that slides inside clogged leg arteries, where it cuts through and vacuums out hard plaque blockages and squishier clot-like substances
Report: Medrad to buy Pathway for $125M
The company has raised $130 million of investment capital and has a staff of 170 employees today (2011)
The medical device maker won FDA approval for its first product 2008